American International Group’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-215
Closed -$46K 3174
2022
Q1
$46K Sell
215
-15
-7% -$3.14K ﹤0.01% 2871
2021
Q4
$63K Sell
230
-7
-3% -$2.67K ﹤0.01% 2887
2021
Q3
$125K Sell
237
-5
-2% -$3.11K ﹤0.01% 2694
2021
Q2
$183K Sell
242
-7
-3% -$5.11K ﹤0.01% 2557
2021
Q1
$192K Buy
249
+40
+19% +$34.8K ﹤0.01% 2394
2020
Q4
$110K Buy
209
+140
+203% +$114K ﹤0.01% 2606
2020
Q3
$70K Buy
69
+10
+17% +$14.5K ﹤0.01% 2729
2020
Q2
$65K Buy
+59
New +$38.6K ﹤0.01% 2778

Other funds holding IBIO

American International Group's IBIO Position: Q2 2022 in Review

American International Group sold out of iBio (IBIO) in Q2 2022, closing a stake of 215 shares — an estimated $46K sold.

American International Group first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $192K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • American International Group reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 215 iBio shares in Q2 2022, an estimated $46K.
  • American International Group first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • American International Group's iBio position peaked at $192K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.